Literature DB >> 22705727

Tissue cholesterol content alterations in streptozotocin-induced diabetic rats.

Xin-ting Wang1, Jia Li, Li Liu, Nan Hu, Shi Jin, Can Liu, Dan Mei, Xiao-dong Liu.   

Abstract

AIM: Diabetes is associated with elevated serum total cholesterol level and disrupted lipoprotein subfractions. The aim of this study was to examine alterations in the tissue cholesterol contents closely related to diabetic complications.
METHODS: Intraperitoneal injection of streptozotocin was used to induce type 1 diabetes in adult male Sprague-Dawley rats. On d 35 after the injection, liver, heart, intestine, kidney, pancreas, cerebral cortex and hippocampus were isolated from the rats. The content of total and free cholesterol in the tissues was determined using HPLC. The ATP-binding cassette protein A1 (ABCA1) protein and ApoE mRNA were measured using Western blot and QT-PCR analyses, respectively.
RESULTS: In diabetic rats, the level of free cholesterol was significantly decreased in the peripheral tissues, but significantly elevated in hippocampus, as compared with those in the control rats. Diabetic rats showed a trend of decreasing the total cholesterol level in the peripheral tissues, but significant change was only found in kidney and liver. In diabetic rats, the level of the ABCA1 protein was significantly increased in the peripheral tissues and cerebral cortex; the expression of ApoE mRNA was slightly decreased in hippocampus and cerebral cortex, but the change had no statistical significance.
CONCLUSION: Type 1 diabetes decreases the free cholesterol content in the peripheral tissues and increases the free cholesterol content in hippocampus. The decreased free cholesterol level in the peripheral tissues may be partly due to the increased expression of the ABCA1 protein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22705727      PMCID: PMC4011154          DOI: 10.1038/aps.2012.50

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  53 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Cholesterol, A beta and Alzheimer's disease.

Authors:  T Hartmann
Journal:  Trends Neurosci       Date:  2001-11       Impact factor: 13.837

3.  Spontaneously diabetic Ins2(+/Akita):apoE-deficient mice exhibit exaggerated hypercholesterolemia and atherosclerosis.

Authors:  John Y Jun; Zhexi Ma; Lakshman Segar
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-03-29       Impact factor: 4.310

4.  Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes.

Authors:  I Shimomura; Y Bashmakov; S Ikemoto; J D Horton; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

5.  ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages.

Authors:  J F Oram; R M Lawn; M R Garvin; D P Wade
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

6.  Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack.

Authors:  R A Zager
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

7.  Reactivity of key metabolic sterols in standard colorimetric assays for cholesterol.

Authors:  C P Sarkar; R J Cenedella
Journal:  Lipids       Date:  1982-01       Impact factor: 1.880

8.  The measurement of the exchangeable pools of cholesterol in the baboon.

Authors:  J D Wilson
Journal:  J Clin Invest       Date:  1970-04       Impact factor: 14.808

9.  Polyunsaturated fatty acids and acetoacetate downregulate the expression of the ATP-binding cassette transporter A1.

Authors:  Yoshinari Uehara; Thomas Engel; Zhengchen Li; Christian Goepfert; Stephan Rust; Xiaoqin Zhou; Claus Langer; Christian Schachtrup; Johannes Wiekowski; Stefan Lorkowski; Gerd Assmann; Arnold von Eckardstein
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

10.  Whole body and tissue cholesterol turnover in the baboon.

Authors:  R B Dell; G E Mott; E M Jackson; R Ramakrishnan; K D Carey; H C McGill; D S Goodman
Journal:  J Lipid Res       Date:  1985-03       Impact factor: 5.922

View more
  6 in total

Review 1.  Sarcolemmal dependence of cardiac protection and stress-resistance: roles in aged or diseased hearts.

Authors:  Louise E See Hoe; Lauren T May; John P Headrick; Jason N Peart
Journal:  Br J Pharmacol       Date:  2016-09-09       Impact factor: 8.739

Review 2.  Overlapped metabolic and therapeutic links between Alzheimer and diabetes.

Authors:  Waqar Ahmad
Journal:  Mol Neurobiol       Date:  2012-09-26       Impact factor: 5.590

Review 3.  Alterations in function and expression of ABC transporters at blood-brain barrier under diabetes and the clinical significances.

Authors:  Li Liu; Xiao-Dong Liu
Journal:  Front Pharmacol       Date:  2014-12-10       Impact factor: 5.810

4.  VEGF-B signaling impairs endothelial glucose transcytosis by decreasing membrane cholesterol content.

Authors:  Christine Moessinger; Ingrid Nilsson; Lars Muhl; Manuel Zeitelhofer; Benjamin Heller Sahlgren; Josefin Skogsberg; Ulf Eriksson
Journal:  EMBO Rep       Date:  2020-05-24       Impact factor: 8.807

5.  Low Molecular Weight Fucoidan Can Inhibit the Fibrosis of Diabetic Kidneys by Regulating the Kidney Lipid Metabolism.

Authors:  Yan Wang; Yanlei Sun; Fengli Shao; Bo Zhang; Zhen Wang; Xinpeng Li
Journal:  J Diabetes Res       Date:  2021-11-24       Impact factor: 4.011

6.  Insulin deficiency and intranasal insulin alter brain mitochondrial function: a potential factor for dementia in diabetes.

Authors:  Gregory N Ruegsegger; Shankarappa Manjunatha; Priska Summer; Srinivas Gopala; Piotr Zabeilski; Surendra Dasari; Patrick M Vanderboom; Ian R Lanza; Katherine A Klaus; K Sreekumaran Nair
Journal:  FASEB J       Date:  2019-01-24       Impact factor: 5.834

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.